Cantab Pharmaceuticals (Acquired By Xenova 2003) is Drug Delivery in United Kingdom that focus on drug formulations business. Founded in 1989. They cover business area such as developer, drug, Cantab, pharmacokinetic, pharmacodynamic, immunogenicity, biosuperior protein therapeutic.
1989
( 35 years old in 2024 )
Drug Formulations
-
155 Cambridge Science Park
Milton Road
Cambridge CB4 0GN
England, United Kingdom
Private
developerdrugCantabpharmacokineticpharmacodynamicimmunogenicitybiosuperior protein therapeutic
* We use standard office opening hours in near Cantab Pharmaceuticals (Acquired By Xenova 2003)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Cantab Pharmaceuticals (Acquired By Xenova 2003) is Drug Delivery business from United Kingdom that founded in 1989 (35 years old in 2024), Cantab Pharmaceuticals (Acquired By Xenova 2003) business is focusing on Drug Formulations.
Cantab Pharmaceuticals (Acquired By Xenova 2003) headquarter office and corporate office address is located in 155 Cambridge Science Park Milton Road Cambridge CB4 0GN England, United Kingdom.
Cantab Pharmaceuticals (Acquired By Xenova 2003) was founded in United Kingdom.
In 2024, Cantab Pharmaceuticals (Acquired By Xenova 2003) is currently focus on drug formulations sector.
Above is snippet of Google Trends for "drug formulations" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Cantab Pharmaceuticals (Acquired By Xenova 2003), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
